Everhart Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Buy
+2,947
New +$245K 0.02% 415
2025
Q3
– Sell
-2,525
Closed -$220K – 396
2025
Q2
$220K Buy
+2,525
New +$198K 0.03% 323
2024
Q3
– Sell
-2,280
Closed -$259K – 321
2024
Q2
$259K Buy
2,280
+164
+8% +$20.7K 0.07% 244
2024
Q1
$293K Buy
+2,116
New +$266K 0.09% 215
2023
Q3
– Sell
-1,678
Closed -$216K – 218
2023
Q2
$216K Buy
+1,678
New +$203K 0.09% 201

Other funds holding DXCM

Everhart Financial Group's DXCM Position: Q3 2026 in Review

Everhart Financial Group opened a new position in DexCom (DXCM) in Q3 2026: 2,947 shares worth $254K. The stake represents 0.02% of the portfolio and ranks #415 among its holdings. This is a return to the name: Everhart Financial Group previously reported a position in DXCM as recently as Q2 2025.

Everhart Financial Group first reported a position in DXCM in Q2 2023 and has held it in 5 quarters since. The position peaked at $293K in Q1 2024. 41 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Everhart Financial Group held 2,947 shares of DexCom worth $254K as of Q3 2026.
  • DexCom was a new Everhart Financial Group position in Q3 2026.
  • DexCom made up 0.02% of Everhart Financial Group's portfolio in Q3 2026, its #415 holding.
  • Everhart Financial Group first reported a position in DexCom in Q2 2023 and has held it in 5 quarters since.
  • Everhart Financial Group's DexCom position peaked at $293K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Everhart Financial Group's 13F filing for Q3 2026, filed 8 Oct 2026.